Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Townsend tells us about lessons to be drawn from the history of immunology in Oxford, from 1979 onwards, until his current research on active and passive immunity to influenza.

All these developments happened in Oxford because the atmosphere was right, open, researchers were encouraged to explore, and there was an enthusiasm in a great environment. Experiments and discoveries were made possible by the very open attitude of the supervisors at the time, telling their team that they they could do anything they wanted.

Professor Alain Townsend

Molecular control of iron homeostasis

alain-headshotProfessor Alain Townsend is a cellular and molecular biologist, based at the Weatherall Institute of Molecular Medicine. He studies the presentation of influenza antigens by class I molecules of the major histocompatibility complex (MHC). In recent years his interest has extended to class I molecules that have functions other than antigen presentation. A particular focus is the HFE gene, which is mutated in individuals with Hereditary Haemochromatosis – who continually absorb excess iron from the diet. As progressive iron loading is correlated with survival in patients with HIV/AIDS, Professor Townsend also studies the interaction between iron and HIV-1 with the aim to limit viral growth.

Professor Townsend's group is part of the Radcliffe Department of Medicine.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.